Trial site
Minneapolis Heart Institute
Minneapolis, Minnesota 55407, United StatesNot linked to an institution yet
- 18running trials
- 6closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Active, not recruiting12 trials
- Completed5 trials
- Recruiting5 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals5 trials
- Abbott Medical Devices4 trials
- Biosense Webster, Inc.2 trials
- M.A. Med Alliance S.A.2 trials
- Biotronik, Inc.1 trial
- and 10 more
Running trials
Active, not recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263· Phase 3· Novartis Pharmaceuticals· Source
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
NCT07286578· Fundación EPIC· Source
Contact: CAROLINA FOCELLA
Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
NCT06898515· Reprieve Cardiovascular, Inc· Source
Contact: Annemarie Forrest
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195· Abbott Medical Devices· Source
Contact: Kate Jappe
Active, not recruiting
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098· Biosense Webster, Inc.· Source
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638· Orchestra BioMed, Inc· Source
Contact: Steven J. Evans, MD
Active, not recruiting
SELUTION 4 De Novo Small Vessel IDE Trial
NCT05946629· M.A. Med Alliance S.A.· Source
Active, not recruiting
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
NCT05360446· Phase 3· Novartis Pharmaceuticals· Source
Active, not recruiting
SELUTION SLR™ 014 In-stent Restenosis
NCT04280029· M.A. Med Alliance S.A.· Source
Recruiting
The HALT Biomarker Study
NCT04552275· Phase 1· Massachusetts General Hospital· Source
Contact: Santiago Garcia, MD (principal investigator)
Active, not recruiting
Portico Next Generation Approval Study
NCT04011722· Abbott Medical Devices· Source
Active, not recruiting
AMPLATZER PFO Occluder Post Approval Study
NCT03309332· Abbott Medical Devices· Source
Active, not recruiting
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
NCT02922036· EBR Systems, Inc.· Source
Active, not recruiting
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis
NCT03042104· Edwards Lifesciences· Source
Active, not recruiting
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
NCT03108456· Abbott Medical Devices· Source
Active, not recruiting
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
NCT02661451· Cardiovascular Research Foundation, New York· Source
Active, not recruiting
A Study of the ReCor Medical Paradise System in Clinical Hypertension
NCT02649426· ReCor Medical, Inc.· Source
Recruiting
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
NCT02061436· Minneapolis Heart Institute Foundation· Source
Contact: Emmanouil S Brilakis, MD, PhD
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error